Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Is triple negative a prognostic factor in breast cancer?

Breast cancer (Tokyo, Japan) - 1 Jan 2008

Nishimura Reiki, Arima Nobuyuki

Abstract excerpt

BACKGROUND: Breast cancer is characterized by hormone dependency, and endocrine therapy is a key treatment in breast cancer. Recently, targeted therapies such as Trastuzumab treatment for HER2-positive breast cancer has been important. Triple-negative (TN) breast cancer is characterized by lack o...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Immunoenzyme Techniques
Share to Neoplasm Staging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Survival Rate

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 18369692
DOI: 10.1007/s12282-008-0042-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18369692-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Is triple negative a prognostic factor in breast cancer?PMID 18369692Read ↗

Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer.Semantic proximity Read ↗

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer.Semantic proximity Read ↗

Prognostic impact of triple negative phenotype in conservatively treated breast cancer.Semantic proximity Read ↗

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients.Semantic proximity Read ↗

Impact of triple negative phenotype on breast cancer prognosis.Semantic proximity Read ↗

Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expressionSemantic proximity Read ↗

Prognostic markers in triple-negative breast cancer.Semantic proximity Read ↗

Ki-67 as a prognostic marker according to breast cancer molecular subtypeSemantic proximity Read ↗

Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast CancerSemantic proximity Read ↗

Outcome of triple-negative breast cancer in patients with or without deleterious BRCA mutations.Semantic proximity Read ↗

[Prognostic significance of Ki-67 expression before and after neoadjuvant chemotherapy in different biological breast cancer phenotypes].Semantic proximity Read ↗

Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer patients who received platinum-containing chemotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.